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Introduction
Chemotaxis is a sensory and behavioral process by which bacteria migrate toward 
higher concentrations ot attractant and lower concentrations of repellent. In an 
isotropic medium, B. subtilis exhibits a "random walk" of swims interspersed by 
tumbles that serve to reorient the cell randomly. When headed "uphill* in an attractant 
concentration gradient or "downhill" in a repellent concentration gradient, the cell 
suppresses the tumble mechanism, thus ensuring continued migration in the favorable 
direction; conversely, when faced with negative stimuli the bacterium tumbles more 
frequently than normal.1
£. coll and S. typhlmurlum possess membrane receptors popularly known as 
methyl-accepting chemotaxis proteins (MCP’s) owing to their ability to be reversibly 
methylated at glutamate residues on their cytoplasmic domain ;2 meihylation of these 
sites results in attenuation of the receptors, enabling them to respond to different 
ambient levels of attractant.® Meihylation of MCP's and methyl-group transfer in B. 
subtills, however, is believed to play a more central role in the chemotactic excitation 
process in that organism. Evidence exists for methyl-group transfer from B. subtilis 
MCP's to a cytoplasmic methylated intermediate which is either directly or indirectly 
involved in conveying signal to the switch apparatus.4 Isolation and characterization of 
such a putative molecule might unravel some of the intricacies of the excitation process 
in B. subtills chemotaxis.
In addition, mutants in each of the twenty chemotaxis complementation groups exhibit 
unique phenotypes when characterized using tethering assays and methanol evolution 
assays. choL, a particularly Interesting mutant, does not evolve methanol or reverse 
rotation of its flagella upon either addition or removal of attractant or repellent.®-® 
This mutation is on the 10.9 kb EcoRI fragment which is part of the chemotaxis operon 
located between pyrD and thyA on the B. subtilis chromosome.7-® Localization of the
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5cheL gene to its exact position on this fragment will facilitate its cloning so subsequent 
physiological studies of the effects of its product can be conducted.
Materials ana Methods
Chsmlcals: L-[mefhy/-3H]methionine (75-80 Ci/mmol) and S- adenosyl-
(mefhy/-3H)methlonine (75 Ci/mmol) (SAM) were obtained from Amersham Corp., 
New England Nuclear, or ICN. Electrophoresis reagents were all electrophoresis grade. 
All other chemicals were reagent grade.
Solutions and Media: Tryptone broth (TBr) is 1% tryptone, 0.5% NaCI. Luria Broth
(LBr) Is 1% tryptone, 0.5% yeast extract, and 0.5% NaCI. Effective selective 
concentrations for antibiotics were as follows: ampicillin- 50pg/ml, chloramphenicol- 
5pg/ml, and kanamycin- 5pg/ml. Chemotaxis buffer and methyltransferase buffer are 
as described previously.® TE buffer is 10 mM tris, 1 mM EDTA, pH 7.6.
In VStro Methylatlons: In vitro methylations were performed as described by Goldman 
and Ordal.10 The tubes consisted of 2.5 pi of 1100 membranes (about 70-80 pg of 
protein), 5 p i of 50mM MgCIo, 25 pi of mixtures of 1100 and mutant crude 
supernatants, 5 pi of 1M effector (either KCI or KAsp), and 5 pi of SAM. The reaction 
mixture was allowed to incubate for 1 hour at which time the reaction was terminated by 
addition of 50 pi of 2X Laemmli sample buffer (SDS solubilizer).
Polyacrylamide Gal Electrophoresis: SDS-PAGE was performed by the method of
Laemmli.11 Samples were solubilized by boiling 5 minutes in SDS solubilizer and then 
applied to sodium dodecyl sulfate-polyacrylamide 8-20 % gradient gels. Gels were 
prepared by the method of Laskey and Mills.12
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Stra ins: 011085 is a chemotactically wild-type strain of B. subtilis and is trpF7,
hisH2, metC. 011100, a chemotaxis mutant, was obtained from 011085 by mutagenesis 
and is deficient in methyltrartsferase II. 011773 was obtained from 011745 by 
transposon insertion and is also a chemotaxis mutant. 011878 is a 1085 derivative that 
is r ,  trp", leu \ 2156 is E. Coli JM101 harboring pBGSC6. 2185 is E  Coti 
JM103 transformed with pFP101. 2193 is a chemotaxis mutant of 011878 that was 
insertionally inactivated in the che region through transformation with pFP101. 
011130 and 011090 are cheL mutants.
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Plasmids: pBGSC6 is a 3.85 kB plasmid that was obtained from the University of Ohio 
Bacillus Genetics Center. It was constructed by linearizing pUC19 at its single Ssp I 
site and inserting the 1170 bp Dra I fragment of pCI94. It confers resistance to 
ampiciilin (40pg/ml) and chloramphenicol (5pg/ml). There Is a polycloning site in 
the lacZ  gene and therefore inserts give rise to ia c Z \  white colonies on X-Gal Amp 
plates whereas non-recombinants are blue. Since there is no origin of replication in 
B. subtilis, it serves as a useful integration vector in this organism.
PFP101 was constructed by cloning in the 2.1 kb Pst I end-digested fragment from 
the 10.9 kb chemotaxis fragment into the polycloning site in pBGSC6.
pFP102 is a recombinant plasmid probably containing the 1.9 kb Sat l/EcoRV 
fragment in pWT18, a derivative of pUC18 confering resistance to kanamycin and 
containing a strong B. subtilis promoter upstream of the polycloning site. pFP103 
probably contains two inverted copies of the 1.9 kb Sai l/EcoRV fragment end-ligated 
to one Sal I site in the polycloning region and another Sai I site internal to the lacZ  
gene in pW H9 (similar to pW H8 in every respect except in that it contains the 
promoter oppositely oriented with respect to the polycioning site). For diagrams of the 
plasmids and the restriction maps of the chemotaxis operon, see the Figures section.
Restrictions and Ligations: Restriction digests were performed in 20pl volumes using
8pl of plasmid DNA and .5pl of restriction enzymes. Pst lf Sal I, EcoRI. and EcoRV, 
were all from Bethesda Research Laboratories as were the 10X reaction buffers. 
Incubations were for 1 hr. The reactions were stopped by heat-shocking the enzymes at 
65°C and then placing the tubes on ice. Ugations were done after ethanol precipitating 
the cut vector and DNA to be ligated, then resuspending in a volume of 20pl containing 
4pl 5X ligation buffer (from BRL) and .1pl T4 DNA ligase. The tubes were incubated 
overnight at 15°.
Plasmid Minipreps: E. coli plasmid minipreps were done as described by Maniatis. 13 
8. subtilis minipreps were modifications of Kawamura's method14; a phenol/CHCl3 
extraction was carried out before resuspending the plasmid pellet in TE buffer. This 
minimized loses of plasmid due to DNases.
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Large Scale Plasmid Purification Method: A large scale purification of pBGSC6 was 
done to recover large quantities of this plasmid from strain 2156 (£. co//JM 101). 
500 mis of cells were grown in LBr to stationary phase, and the bacteria harvested by 
centrifuging at 6.5K rpm in 250 ml centrifuge bottles for 15 min. The pellets were 
resuspended in JO ml SET buffer (20% sucrose, 50 mM Tris pH 7 6, 50 mM EDTA, 50 
mg lysozyme/30 ml SET), then 70 ml of Lytic mixture (1% SDS, 0.2 N NaOH) was 
added and the bottles were cooled on ice for 15 min. The solutions were then swirted 
gently and incubated at 50°C for 15 min , then transferred to an ice bath and left 
standing for 25 min. 50 ml of 1.5 M K Acetate buffer pH 4.8 was added to precipitate 
the SDS and chromosomal DNA at this stage; the solution was placed on ice for 40 min. 
The precipitate was removed by centrifuging at 4°C, 6.5 K rpm for 20 min. The 
supernatant was poured through two Kimwipes placed on a funnel into 250 ml centrifuge 
bottles. 0.2 mi of RNase (10 mg/ml) was added and incubation of the solution at 37°C 
for 20 min carried out. At this point an equal volume of isopropanol was added, the
9solution mixed, and left standing for 15 min before centrifuging at 6.5 K rpm for 20 
min at 20°C. The plasmid DNA pellet was resuspended in 8 ml of TEN buffer (10 mM 
Tris, pH 7.6, 1 mM EDTA, 10 mM NaCI), 0.3 ml of a 5 M NaCI solution was added and 
two 1:1 phenolrchloroform extractions were done using an equal volume of the phenol. 8 
ml of hydrated ether was used to extract any remaining phenol; the residual ether was 
blown off with Ng. The tubes were centrifuged 20 min. at 6.5 K rpm at 20°C and the 
pellet was washed with 10 mi of 70% ethanol (room temp.). The ethanol was poured off 
and the pellet was resuspended in .7 ml of TE buffer.
Preparation of Competent Cells and Transformations: Competent E. coli JM103 were 
prepared by first growing up an overnight culture in 4 ml LBr (0.1% glc). 1 ml of this 
culture was added to 50 ml of prewarmed LBr (0.1% glc) and incubated at 37°C until 
the Abs$5o nm was between 0.4 and 0.6. The culture was immediately placed on ice and 
kept chilled from here on. 20 ml of the culture were centrifuged in a sterile 30 ml 
Corex tube at 5 K rpm for 15 min. at 4°C. The pellet was resuspended in 10 ml (1/2 
vol.) ice-cold 50 mM CaCl2 and incubated on ice for 1 hr. The ceil suspension was re­
centrifuged at 5 K rpm for 15 min at 4°C and the pellet was resuspended gently in 4 ml 
(1/10 vol.) ice-cold 50 mM CaCl2 The cells were kept on ice for 24 hrs. for maximal 
development of competence.
Transformations of JM103 were done by adding 100pl competent cells to 50pl TE 
buffer containing either a "no DNA" control, or 1-50 ng plasmid DNA in an eppendorf 
tube. The tubes were incubated on ice for 40 min. the transferred to a 42°C bath and 
incubated 2 more min. The contents of the tubes were transferred to a test-tube 
containing 1.35 mi of prewarmed LBr (0.1% glc) and incubated at 37°C for 60 min. to 
allow phenotypic expression. 100pl of undiluted cells and 10 '1 dilutions were plated 
out on selection plates.
Preparation of competent B. subtilis and transformation was performed by the 
method of Doi.15
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Electrophoretic Elution of DNA Fragments: The original 2.1 kb Pst I end-digested 
fragment was purified away from its pUC-19 vector through this procedure. The 
restriction digests were electrophoresed in a 1% agarose gel until the insert was clearly 
resolved from the vector. At this point, using long-wavelength UV light for visualization 
to minimize damage to DNA, the insert band was cut out carefully around its border. 
This was placed in a dialysis tube and electrophoresed in TE buffor at 100 mAmps until 
the ethidium bromide-stained DNA was seen to have moved out of the gel. The gel piece 
was then removed from the dialysis tube and .4 ml of TE buffer was added and the 
contents of the tube massaged gently. Any small pieces of agarose were removed by 
centrifugation and if necessary the purified fragment was ethanol precipitated to 
concentrate the DNA.
Results
A. Searching {or the Methylated Chemotaxis Intermediate in B. subtilis.
Strong evidence has been found suggesting that there exists a molecule capable of 
rapidly accepting methyl or methoxy groups from B. subtilis MCP’s when they bind 
attractant; this putative methyl carrier releases these groups as methanol during the 
excitatory or smooth swimming period.19,1^ Methanol evolution, presumably from 
demethylation of this intermediate, has been correlated with smooth swimming; this 
suggests that the methylation status of this intermediate methyl carrier might serve as 
an excitatory signal. It is incumbent upon us to show that such a molecule exists by 
isolating it.
What characteristics might we expect of such a molecule? First of all, as per our 
model, it must be capable of accepting tritiated methyl/methoxy groups from tritium- 
methylated MCP’s upon addition of attractant. Also, it would probably be a cytoplasmic 
protein, perhaps a relatively small molecule.
The LMMS bands Initially showed promise as candidates for the intermediate.18 
LMMS II (17 kD), the smaller of the doublet band, is methylated upon stimulation by 
aspartate in in vitro methylations. This molecule was shown to be cytoplasmic, but 
does not require a membrane component or methylated LMMS I for its own methylation. 
LMMS II is probably methylated de novo from SAM , rather than from the MCP's, and is 
therefore not likely to be the intermediate. LMMS I (21 kD) requires membranes for 
its ( wn methylation, but is not aspartate-stimulated.19 A good candidate for the 
intermediate would be able to accept label only from the MCP’s and to show increases in 
labelling upon stimulation by attractant.
Vitro Complementation of 1773 Extracts with Qinoo Extracts Results in 
Resolution of a Methylated Doublet
11
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1773, a transposon insertion mutant, shows an inability to methylate its MCP's in 
v i v o However, in in vitro methylations the MCP's are resolved when some 1085 
crude supernatant is a d d e d . T h e  missing component in vivo is probably some 
methylesterifying activity that is present in 1085. In vitro methylations of 1100 
membranes were carried out using 1773 crude supernatant along with 1100 crude 
supernatant (see Materials and Methods) because these were known to have good 
methylesterase activity.
As seen in Figure 1, lanes 1 and 2, the addition of .1M KAsp to in vitro methylation 
reactions containing only 25ul 1773 supernatant results in a transfer of some label 
from MCP's to LMMS II as expected. However, using 12.5pl each of 1773 and 1100 
supernatants in combination results in transfer of label upon aspartate stimulation from 
MCP's to a previously unobserved doublet resolved midway between the MCP's and the 
LMMS bands. (Figure 1, lanes 3 and 4) The total label in the MCP's and the doublet is 
about the same in both lanes; that is, label lost by MCP's appears to be found in the new 
doublet.
Figure 2 shows that when 1773 supernatant levels are kept constant and 1100 
supernatant varied vs. MT buffer, the appearance of the doublet is dependent on the 
concentration of 1100 supernatant. Something in 1100 crude cytoplasmic extracts was 
causing genesis of this doublet band.
To see whether this methylated doublet required a membrane component, 1100 
membranes were excluded from reaction mixtures that had I2.5pl each of 1100 and 
1773 crude supernatant (the membranes were replaced with MT buffer). The doublet 
failed to appear (data not shown). We concluded that this molecule had at least two of the 
salient characteristics we would expect for a B. subtills methylatod chemotaxis 
intermediate: it responded to aspartate and required a membrane component.
What did 1100 have that 1773 was deficient in? The inability of 1773 to methylate
its own MCP's in vivo suggested that cold methyl groups were present on the glutamate 
residues of these membrane receptors due to lack of a demethylating enzyme. For this 
reason, a partial purification of B. subtilis chemotactic methylesterase was done on a 
CM-Blogel column and assayed in Conway Diffusion Cells according to the method of 
Nettleton22. This enzyme was used as the complementing factor instead of 1100 crude 
extract. However, the doublet did not appear (data not shown). Previously purified 
chemotactic methylesterase did not appear to be the complementing factor.
It was then decided that a fractionation of 1100 extract should be performed through 
ion-exchange chromatography, and the individual fractions tested for their ability to 
restore the doublet in the original in vitro complementation assays. Figure 3 shows the 
results of this experiment which was performed by Ralph Brown. O il 100 crude 
cytoplasmic extract was fractionated on a DEAE-cellulose column using a 0 to 0.6M NaCI 
linear salt gradient followed by a step Increase to 1M NaCI; 7 fractions were collected. 
Either the activity that gives rise to the doublet, or the doublet itself, was seen to elute 
around .5M NaCI. On the basis of this experiment we can see that the protein is anionic, 
not basic like chemotactic methylesterase as originally conjectured; if it is an enzyme 
that was purified, it is definitely not chemotactic methylesterase since methylesterase 
will not bind a DEAE column.
There are several possible explanations for these results. The intermediate itself 
r «’ght be absent in 1773 extracts and 1100 returns this, or the activity that transfers 
methyl groups to the intermediate might be absent. In the first case, the combination of 
1773 and 1100 extract results in methylating conditions since the methyltransferase, 
MT II, that transfers methyl groups from SAM to the MCP's is present (from 1773) and 
methylesterase to remove methyl groups from the MCP's is present in 1100 (this is 
evident from the fact that 1100 will demethylate methylated MCP's to give methanol in 
Conway Cells). This would explain the inability of 1773 to methylate Its membranes in 
vivo; if methyl transfer cannot occur from the MCP's to an acceptor, "cold” methyl 
groups will be present on the MCP's and the lack of turnover would preclude labeling of 
the MCP's with "hot” groups from 2H-SAM. Perhaps a methyltransferase in 1100,
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absent in 1773, is causing transfer of methyl groups from MCP's to the intermediate. 
This too would explain why methyl groups are 'stuck* on 1773 MCP's.
It is interesting that a mixture of 1/2 1100, 1/2 1085 (source of MT II to label 
1100 membranes) gives rise to a very faint doublet band upon stimulation by 
aspartate.23 In wild-type methylations of this sort the activity that breaks down the 
methylated intermediate must be especially active. Perhaps 1773 lacks this activity as 
well. But since the mutant was created through Tn917 transposon insertion 
mutagenesis, only one protein should be missing. However, polar effects can occur if the 
transposon inserts at the interface between two genes or if translational coupling occurs.
Further fractionation of the OEAE fraction needs to be performed to purify the 
intermediate/enzyme. In addition, genetic studies of 1773 need to be undertaken, such 
as determining where the insertion is and whether or not it has polar effects.
C. The cheL Mutation: The chef, mutation exhibits fascinating phenotypes. 011130, a 
cheL mutant, is unresponsive in tethering assays to both addition and removal of 10.0 
mM aspartate and .3pM FCCP.23 Behaviorally, therefore, it is a ‘dud*, never changing 
its direction of flagellar rotation. Even more interesting it never evolves methanol, 
unlike 011085, upon addition and removal of attractant and repellent (see graph in 
figure 4 kindly provided by J. Kirby). This result is a powerful demonstration of the 
correlation between behavior and methyl group flow in B. sublilis chemotaxis.
In accordance with our intention to develop the behavioral genetics of B. subtilis, we 
need to clone all the genes associated with the 21 complementation groups of chemotaxis 
in that organism. The cheL mutation is outstanding in its ability to correlate methyl 
flow with chemotaxis in B. subtitle; we must clone the cheL gene.
D. Localization of the ehwtMntatinn: The cheL mutation is on the 10.9 kb EcoRI end- 
digested fragment from the chemotaxis operon located between pyrD and thyA on the
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B. subtilis chromosome (see figure 5 for the restriction map of the chemotaxis 
operon).24,25 The mutant allele has been mapped to a 2.1 kb Pst I end-digested 
fragment, near one end of the 10.9 kb fragment, through recombination of this fragment 
in a pUC vector with 011130 (see figure 5).26 Whether or not the entire gene is 
present on this fragment is what we asked.
The Termini of the B, subtilis Chemotaxis Qperon: Does this 2.1 fragment contain an
operon terminus, either a promoter or a terminator loop? If so, then integration of this 
fragment at its homologous site on the chromosome would result in normal chemotaxis 
for 1878, a derivative of wild-type 1085 (see Discussion section for explanation).
pBGSC6, a useful integration vector for B. subtilis, was obtained from the Bacillus 
Genetics Center at the University of Ohio. Strain 2156 harbored this plasmid. A large 
scale purification was done and 2 ml of 2 mg/ml plasmid DNA was obtained. Its purity 
was confirmed by agarose gel electrophoresis.
The 2.1 kb Pst I end-digested fragment was electrophoretically eluted from its 
pUC19 vector and ligated to Pst l-cut pBGSC6. The ligation mixture was used to 
transform JM103. Recombinant plasmids in transformants gave flat, white colonies on 
X-gal, ampicillin plates; non-recombinant transformants were blue due to expression of 
the p- galactosidase gene product. Inserts in 2185, a recombinant transformant were 
confirmed by Pst I digestion and gel electrophoresis (see figure 7). Plasmid DNA from 
strain 2185 was used to transform 011878 (011085 that is r ’ , trp~, leu’ ). 
Transformants were selected on 5pg/ml TBAB plates and then screened for chemotaxis on 
HMTL mannitol swarm plates. Ail transformants were che’ \ the swarm phenotype was 
not like cheL indicating inactivation of downstream genes (see Discussion).
The 2.1 Pst I end-digested fragment therefore does not contain the terminus tor 
either the cheL  gene or the rest of the chemotaxis operon. It is known that 
transcription of the 7.7 kb and 4.0 kb regions is neither initiated nor terminated from 
within that region.27 Recent results indicate that the promoter for this region is in the
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4.1 kb EcoRI/Ssf I end-digested fragment upstream of the 7.7 kb region (see figure 
5).2® Whether the entire 10.9 kb region is in the same operon is currently being 
determined. For the 7.7 and 4.0 regions transcription proceeds from the 7.7 into the 
4.0 region. If the 10.9 is contained in the same operon, the genes will be oriented from 
right to left on the map of the 10.9 in figure 5.
E. Complementation of the CheL Gene: Is the entire of cheL present on the 2.1 kb 
fragment? If so, we would expect to get complementation of strain 1130 (cheL) when 
this fragment is in an expression vector next to a promoter. Transformation of 1130 
with this 2.1 fragment In a pSI-1 expression vector does not result in complementation 
(data not shown). cheL is probably not present in Its entirety on the 2.1 fragment.
In an effort to test flanking regions of the 2.1 kb Pst I fiagment, the 6.2 kb Sal I 
end-digested fragment was subc>oned into pWTlS and pWTl9, p(JC18 and 19 derivatives 
that contain oppositely oriented promoters upstream of the polycloning site and encode 
kanamycln resistance. The Sal I fragment was cut with EcoRV and the two Sal 
l/EcoRV fragments were cloned into the pWT vectors. These vectors were cut with Sal 
I and Sma I (a bkmt-end cutter like EcoRV). Since the Sma I site is internal to the 
two Sal I sites on pWT19, it is lost; the Sma I site is not in between the Sal I sites in 
pWT 18 and is therefore preserved on the plasmid. Recombinants in pWTis would have 
one Sal l/EcoRV fragment end those in pWT 19 would have two of these fragments in 
tandem and opposite orientation (see Plasmids, figure 6). Transformation of 1130 with 
both pWTig and pWTI# gave many kanamycln resistant colonies. These were screened 
for cHe mo taxis using tryptone swarm plates and HMTL mannitol swarm plates. 75% of 
the p W T lt transformants were chemotaxis+; 40% of the pWTl9 transformants were 
chemotaxis4.
Which of the two Sal 1/fcoRV end-digested fragments was giving complementation? 
Only the one on the left, containing an internal Sal I site, overlaps the 2.1 kb Pst i
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end-digested fragment. This fragment is 1.9 kb in length. The recombinant plasmids 
probably look the way they are depicted in the Plasmids section, figure 6.
It proved difficult to extract plasmid from the transformants; gel analysis showed 
very faint bands. Plasmid from a pWT18 che+ transformant was used to transform 
1130 again. Only one kanamycin resistant colony appeared; it screened positive for 
chemotaxis. The plasmid DNA concentration must have been very low.
In the absence of enough plasmid DNA for gel analysis or for transformation of a large 
number of che f  colonies, we cannot say with certainty that complementation instead of 
recombination occured. We however now know that at least part of the ch e i gene, 
including the part containing the 1130 mutation, is on both the 2.1 kb Pst I end- 
digested fragment as well possibly the overlapping 1.9 Sal l/£coRV fragment.
In order to do complementation analyses correctly, a chei recE4 mutant is desired. 
In the absence of homologous recombination, a che* phenotype will result only from 
complementation through a trans acting factor, the product of the chei gene.
Discussion
A. A Methylated Intermediate in B. subtiiis Chemotaxis.
Chemotaxis in the gram negative bacteria E. coli and S. fyphimurium appears to be 
significantly different than chemotaxis in the gram-positive B. subtiiis. Since these 
organisms diverged from a common ancestor over three billion years ago, it would seem 
logical that each one has evolved its own characteristic mode of behavior to suit its 
respective environmental needs (E. coii and S. typhimurium are enteric bacteria 
whereas B. subtiiis is found in the soil). Although the immediate features are similar 
in each, e.g. migration in a chemoeffector gradient through suppression or prolongation 
of tumbling, reversible methylation of Class-1 type receptors, and adaptation to 
stimulus, the biochemical mechanisms and genetics are vastly different.
Upon stimulation with the attractant aspartate, B. subtiiis demethylates its MCP's 
immediately and evolves methanol all through the excitatory period; adaptation appears 
to occur when levels of some methylated intermediate acceptor drop back down to pre­
stimulus levels. In contrast, methylation of the MCP's in E. coli brings about adaptation 
and is expressly for the purpose of fine-tuning the receptors to respond to a newer 
range of attractant concentrations. For example, mutants in the cheR gene product of 
E. co//, encoding the methyltransferase that methylates MCP's from SAM, are mutants 
in adaptation; they swim almost perpetually. A B. subtiiis mutant in this same 
methyltransferase, 011100, responds poorly to signal; the vehicle for propagation of 
the excitation signal seems lost when methyl flow cannot originate at the receptors.
Evidence for tha existence of a methyl-accepting signalling molecule in B. subtiiis 
chemotaxis, then, is very strong. Recently we have resolved through in vitro 
complementation assays and SDS-PAGE followed by fluorography, a doublet protein band 
centered in between the MCP's and LMMS that shows promise as a contender for this
18
19
title. It is aspartate stimulated and requires a membrane component for its methylation; 
the MCP's appear to lose label concomitant with increase of labelling in this protein. 
The doublet might correspond to different degrees of methylation on a multiply- 
methylated molecule. Is just the activity that gives rise to the methylated form of this 
intermediate, i.e. a methyltransferase, missing in 1773, or is it the actual intermediate 
molecule itself? Perhaps it is a combination of both the^e possibilities; the
intermediate might be capable of auto-methylation using methylated MCP's as substrates 
when they undergo conformational changes upon excitation. In this case, the molecule 
might be similar in design and function to the cheA protein from E. coli that auto- 
phosphorylates.29 What is needed is an efficient assay for this molecule so that the 
biochemistry of the reaction can be studied more closely. Many questions remain: Are 
the methyl linkages on glutamic acid residues? Do tryptic digests of the molecule 
resemble tryptic digests of the MCP's ? Were it to be an MCP degradation product, we 
would not expect to see the apparent methyl transfer from the MCP's that is observed; 
however, it has to be shown that the molecule is cytoplasmically derived.
Our goal to reconstitute all the components of chemotaxis in vitro must go hand-in- 
hand with our ability to show that similar processes occur in vivo. Perhaps this 
doublet band is poorly resolved in in vivo methylations because it is broken down by 
some adaptation enzyme that demethylates it rapidly. A mutant in this particular 
enzyme might show this methylated doublet in in vivo methylations. It will be 
interesting to see if such a mutant is deficient in adaptation.
Methyl transfer to an intermediate methyl acceptor is essential to chemotaxis. We 
report here a candidate for the intermediate that deserves further study.
B. The cheL Gene
A notable difference in the chemotaxis systems of B. subtiiis and E. coli is the
number of gene products required for each. Six genes are required for chemotaxis in E. 
coli whereas twenty-one genes appear to be required for B. subtilis.30  Twenty of 
these genes, referred to as che's "A" through MtT, are located on three EcoRI digested 
fragments (sizes 10.9 kb, 4.0 kb, and 7,7 kb) next to one another in the chemotaxis 
operon between pyrD and thyA. The other mutation cheR, encoding the chemotactic 
methyitransferase, maps near aroF.
cheL, a mutation that results in complete inability to excite as well as a dysfunction 
to evolve methanol, is complemented by the 10.9 kb fragment. In an effort to clone 
cheL we have localized its position to a Sal l/EcoRV fragment at one end of the 10.9 kb 
fragment. It is conceivable that the entire of cheL is present on this fragment, but this 
needs to be confirmed in the absence of homologous recombination, in a recE4 cheL 
strain.
Is the cheL gene in the same transcription unit as the 4.0 kb and the 7.7 kb 
fragments or does it have its own promoter and terminator? In order to find out if the 
original 2.1 kb Pst I fragment is internal to a transcription unit, it was cloned into 
pBGSC6 and the recombinant plasmid pFPl01 was transformed into 011878. a 
derivative of wild-type 011085 that is especially useful for transformations. Since 
pFP101 does not contain an origin of replication, it cannot propagate autonomously in 
B. subtilis; the plasmid has to integrate into the chromosome at the homologous 2.1 
Pst I fragment to confer ampicillin resistance to 1878. If the transformants screen 
che+, it is because the terminus of an operon, either a promoter or terminator is on 
the 2.1 kb fragment. If the transformants are che\ it is because downstream genes in 
the transcription unit cheL  is part of have been insertionally inactivated. All 
ampiciliin resistant transformants screened che ' and swarmed differently than the 
cheL mutant 1130. Downstream genes appeared to have been inactivated; the 2.1 kb 
Pst I fragment is internal to a transcription unit.
The 10.9 kb region might be in the same operon as the 4.0 and the 7.7. Aamir Zuberi 
has recently shown that transcription of this operon begins in a 4.1 EcoRUSst I 
digested fragment that is upstream from the 7.7 fragment. Studies are being done to
20
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ascertain whether thel0.9 contains any operon termini.
The 2.1 hb Pst I fragment was not capable of complementing cheL mutant 1130 by 
itself. However an overlapping 1.9 kb fragment cut with Sal I and £coRV is capable of 
complementing the chaL mutaion. To prove without a doubt that this fragment per se is 
capable of complementation, the experiment needs to be done in a cheL mutant deficient 
in recombination.
Among all the complementation groups, cheL seems to be the most outstanding of the 
mutations capable of correlating methyl group transfer and flow with behavior. As a 
means toward proving the relationship between methylation and chemotaxis, it is 
imperative for us to clone , sequence, and study the physiology of the cheL gene.
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